title: Treatment of benign focal epilepsies in children: when and how should be treated?
abstract: Benign focal epilepsies represent almost one-fourth of all childhood epilepsies and are a frequent occurrence in clinical practice. They include benign infantile seizures (BIS), Panayiotopoulos syndrome (PS), and benign childhood epilepsy with centrotemporal spikes (BCECTS) in this order of the onset age. Because the prognosis is always excellent in patients with benign focal epilepsies, we must consider the risks and benefits of chronic antiepileptic drug (AED) administration. AED treatment is usually not recommended for the patients with a first attack, but should be considered for those with a second or third attack. A choice of AED has been based on the expert opinion. Carbamazepine (CBZ) is recommended for both acute and chronic treatment of seizure clusters in patients with BIS. Valproic acid (VPA), CBZ or clobazam (CLB) appears to be a first option of AED for patients with PS. A common first choice for BCECTS is CBZ in the USA and Japan, and VPA in the EU. The treatment period should be as short as possible without waiting for EEG normalization, possibly within 2 years after the initiation of AED. We must remember that some patients with BCECTS may have an "atypical evolution". In conclusion, when and how to treat this benign condition should be determined in an individual manner based on the length and frequency of seizures, circadian rhythm of the attacks, interictal EEG findings, cognitive and behavioral functions in daily life and the attitude of the parents toward seizure recurrences and AED side effects.
authors.affiliation: Department of Pediatrics, Tokyo Women's Medical University, Tokyo, Japan. hoguni@ped.twmu.ac.jp
authors.forename: Hirokazu
authors.initials: H
authors.lastname: Oguni
mesh_terms: D017668:Age of Onset; D000927:Anticonvulsants / Q000009:adverse effects / Q000627:therapeutic use; D002220:Carbamazepine / Q000009:adverse effects / Q000627:therapeutic use; D002648:Child; D004569:Electroencephalography; D004828:Epilepsies, Partial / Q000188:drug therapy / Q000628:therapy*; D019305:Epilepsy, Rolandic / Q000188:drug therapy / Q000628:therapy; D006801:Humans; D012640:Seizures / Q000209:etiology / Q000628:therapy
chemical_list: D000927:Anticonvulsants; D002220:Carbamazepine